Exelixis
EXEL
#1694
Rank
ยฃ8.96 B
Marketcap
ยฃ33.30
Share price
-0.02%
Change (1 day)
17.89%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company